Espere Healthcare Limited working with researched based partners in Europe and North America - committed to finding innovative solutions for the treatment of various skin related conditions

Espère Healthcare - Bright Sparc Award Finalist.

Espère Feature in Financial Times

Espère Healthcare Ltd, working with researched based partners in Europe and North America is committed to finding innovative solutions for the treatment of various skin related conditions.

We are based at Bedford i-Lab facilities, a business and technology centre providing a link between science parks in Cambridge and Oxford.

DermaSilk Therapeutic Clothing is a major technological breakthrough that helps manage eczema and dermatitis using a patented system that has been proven in published clinical trials to reduce the symptoms of itching. It is the only range of therapeutic clothing supported by product specific clinical data that is registered as a Class 1 Medical Device throughout Europe and listed on the National Health Service Drug Tariff for prescription reimbursement in the United Kingdom.

DermaTherapy Bedding is the first bed linen to receive US FDA clearance to be marketed as a Class 1 Medical Device for the treatment of atopic dermatitis. It can also be useful for people suffering from night sweats such as menopausal women. Recent clinical evidence also points to its usefulness in the management of Pressure Sores.